[144] OppFi Inc. SEC Filing
Rhea-AI Filing Summary
OppFi Inc. (OPFI) Form 144 notice: An affiliate intends to sell 5,497 Class A shares with an aggregate market value of $61,621.37 on or about 10/02/2025 through Fidelity Brokerage Services (NYSE). The shares were acquired by the seller on 10/01/2024 upon restricted stock vesting and were paid as compensation. Total Class A shares outstanding reported in the notice are 28,357,891. The filer also reported prior sales in the past three months: 5,495 shares sold on 07/02/2025 for $73,687.95 and 1,130 shares sold on 08/04/2025 for $11,785.90. The form includes the required signature certification that no undisclosed material adverse information is known to the seller.
Positive
- Disclosure compliance: The seller filed a Form 144, meeting Rule 144 disclosure requirements.
- Equity alignment: The shares were acquired through restricted stock vesting, indicating compensation tied to company performance.
Negative
- Insider sales: Multiple share dispositions in recent months (5,495 on 07/02/2025 and 1,130 on 08/04/2025) may be perceived negatively by some investors.
Insights
TL;DR: Routine Rule 144 sale by an affiliate of recently vested restricted stock; transaction size is modest relative to outstanding shares.
The filing shows a planned sale of 5,497 Class A shares valued at $61,621.37, following acquisition by restricted stock vesting on 10/01/2024. Recent sales in July and August 2025 total 6,625 shares for approximately $85,473.85. Against 28,357,891 shares outstanding, these transactions are small in proportion and represent typical liquidity events for insiders receiving compensation in equity. The notice is procedural and compliant with disclosure requirements.
TL;DR: Insiders disclosed sales under Rule 144 and reaffirmed no undisclosed material information; record shows equity compensation being monetized.
The seller reports shares acquired via restricted stock vesting and subsequent dispositions under Rule 144. The filing includes the standard declaration that the signer is unaware of any undisclosed material adverse information. From a governance perspective, these are routine monetizations of vested compensation. The pattern of multiple recent sales is notable for monitoring but not, by itself, evidence of corporate governance failure.